Skip to content

Released Feb 28, 2023, after the close

10-K filed Feb 28, 2023, 59 days after period end · 0001636422-23-000033

Q4 2022 · 10-K

derived · Computed from the longer spans the company filed.

Revenue$69.16Mderived+6.9% vs Q4 2021+1.2% vs Q3 2022
Net Income-$35.78MderivedN/M vs Q4 2021N/M vs Q3 2022
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$36,745,000N/M
Operating Cash Flowderived-$14,821,000N/M
Free Cash Flowderived-$15,236,000N/M
Margins · derived
Operating margin-53.1%+16.0 pt vs Q4 2021
Net margin-51.7%+24.0 pt vs Q4 2021

What the release said

The release

Same quarter

MetricQ4 2022derived from reported figuresQ4 2021derived from reported figuresQ4 2020derived from reported figuresQ4 2019derived from reported figures
Revenue$69.16M$64.72M$53.28M$43.50M
Net Income-$35.78M-$48.99M-$43.02M-$14.27M

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR